KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Exchange Rate Effect (2016 - 2026)

Bristol Myers Squibb has reported Exchange Rate Effect over the past 18 years, most recently at -$48.0 million for Q1 2026.

  • Quarterly Exchange Rate Effect fell 172.73% to -$48.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Mar 2026, up 411.54% year-over-year, with the annual reading at $195.0 million for FY2025, 242.34% up from the prior year.
  • Exchange Rate Effect was -$48.0 million for Q1 2026 at Bristol Myers Squibb, down from $5.0 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $128.0 million in Q2 2025 and troughed at -$147.0 million in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$4.0 million (2025), against an average of $1.3 million.
  • Year-over-year, Exchange Rate Effect tumbled 494.44% in 2022 and then skyrocketed 681.82% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $95.0 million in 2022, then dropped by 17.89% to $78.0 million in 2023, then tumbled by 288.46% to -$147.0 million in 2024, then soared by 103.4% to $5.0 million in 2025, then plummeted by 1060.0% to -$48.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Exchange Rate Effect are -$48.0 million (Q1 2026), $5.0 million (Q4 2025), and -$4.0 million (Q3 2025).